ALX ONCOLOGY HOLDINGS INC Annual Operating Income (Loss) in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Alx Oncology Holdings Inc quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • Alx Oncology Holdings Inc Operating Income (Loss) for the quarter ending December 31, 2024 was -$30.6M, a 36.3% increase year-over-year.
  • Alx Oncology Holdings Inc Operating Income (Loss) for the twelve months ending December 31, 2024 was -$142M, a 16.3% increase year-over-year.
  • Alx Oncology Holdings Inc annual Operating Income (Loss) for 2024 was -$142M, a 16.3% increase from 2023.
  • Alx Oncology Holdings Inc annual Operating Income (Loss) for 2023 was -$170M, a 33.6% decline from 2022.
  • Alx Oncology Holdings Inc annual Operating Income (Loss) for 2022 was -$127M, a 52.5% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$142M +$27.8M +16.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 -$170M -$42.8M -33.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 -$127M -$43.9M -52.5% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-06
2021 -$83.6M -$39.9M -91.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 -$43.7M -$24.5M -128% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 -$19.2M -$5.5M -40.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$13.7M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.